Verrica Pharmaceuticals (VRCA) Receivables - Other (2022 - 2025)
Verrica Pharmaceuticals has reported Receivables - Other over the past 4 years, most recently at $46000.0 for Q1 2025.
- Quarterly results put Receivables - Other at $46000.0 for Q1 2025, down 92.23% from a year ago — trailing twelve months through Mar 2025 was $46000.0 (down 92.23% YoY), and the annual figure for FY2024 was $29000.0, down 82.74%.
- Receivables - Other for Q1 2025 was $46000.0 at Verrica Pharmaceuticals, up from $29000.0 in the prior quarter.
- Over the last five years, Receivables - Other for VRCA hit a ceiling of $592000.0 in Q1 2024 and a floor of $29000.0 in Q4 2024.
- Median Receivables - Other over the past 4 years was $168000.0 (2023), compared with a mean of $201769.2.
- Biggest five-year swings in Receivables - Other: skyrocketed 957.14% in 2024 and later tumbled 92.23% in 2025.
- Verrica Pharmaceuticals' Receivables - Other stood at $99000.0 in 2022, then soared by 69.7% to $168000.0 in 2023, then crashed by 82.74% to $29000.0 in 2024, then soared by 58.62% to $46000.0 in 2025.
- The last three reported values for Receivables - Other were $46000.0 (Q1 2025), $29000.0 (Q4 2024), and $84000.0 (Q3 2024) per Business Quant data.